LEXINGTON, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company, today presented positive results from a preclinical study ...
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics (the “Company”), a biopharmaceutical company pioneering disease-modifying genetic medicines using its proprietary LNP delivery ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)" report to their offering. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback